Skip to main content
Erschienen in: International Urology and Nephrology 5/2017

02.01.2017 | Nephrology - Original Paper

Association of H. pylori infection with chronic kidney disease among Chinese adults

verfasst von: Xianglei Kong, Dayu Xu, Feng Li, Xiaojing Ma, Hong Su, Dongmei Xu

Erschienen in: International Urology and Nephrology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Some studies have suggested that Helicobacter pylori (H. Pylori) infection was associated with insulin resistance and metabolic syndrome, which may increase the risk of chronic kidney disease (CKD). But there is no conclusive evidence regarding the association between H. Pylori infection and CKD. To help clarify this, we conducted the cross-sectional study to investigate the association of H. pylori infection with CKD among Chinese adults.

Methods

A total of 22,044 adults aged 48.6 ± 14.3 years were enrolled. H. pylori-specific immunoglobulin G antibody titers were measured by ELISA. CKD was defined as estimated glomerular filtration rate (eGFR) less than <60 ml/min/1.73 m2 or presence of proteinuria (urine protein ≥ 1+) assessed using a repeated dipstick method.

Results

Among all participants in this study, the prevalence of H. Pylori infection was 20.6%. As a categorical outcome, the prevalence of decreased eGFR in the H. Pylori infection group was higher than in the non-H. Pylori infection group (1.6 vs. 1.2%, P = 0.04), but the prevalence of proteinuria and the overall CKD were not significantly different between these two groups (1.7 vs. 1.6%, P = 0.65 and 3.0 vs. 2.7%, P = 0.2). After adjusted for age, sex, hypertension, diabetes, body mass index, uric acid, smoking, drinking, total cholesterol, triglycerides, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, the odds of decreased eGFR and proteinuria were not significantly different between the H. Pylori positive and negative subjects.

Conclusions

This study did not find an association between H. Pylori infection and CKD.
Literatur
1.
Zurück zum Zitat El Meguid EI, Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340CrossRef El Meguid EI, Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340CrossRef
2.
Zurück zum Zitat Nugent RA, Fathima SF, Feigl AB, Chyung D (2011) The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 118:c269–c277CrossRefPubMed Nugent RA, Fathima SF, Feigl AB, Chyung D (2011) The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 118:c269–c277CrossRefPubMed
3.
Zurück zum Zitat Chen XN, Pan XX, Yu HJ, Shen PY, Zhang QY et al (2011) Analysis of cardiovascular disease in Chinese inpatients with chronic kidney disease. Intern Med 50:1797–1801CrossRefPubMed Chen XN, Pan XX, Yu HJ, Shen PY, Zhang QY et al (2011) Analysis of cardiovascular disease in Chinese inpatients with chronic kidney disease. Intern Med 50:1797–1801CrossRefPubMed
4.
Zurück zum Zitat Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R et al (2015) US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 66:S1–S305CrossRef Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R et al (2015) US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 66:S1–S305CrossRef
5.
Zurück zum Zitat Zhang L, Wang F, Wang L, Wang W, Liu B et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822CrossRefPubMed Zhang L, Wang F, Wang L, Wang W, Liu B et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822CrossRefPubMed
7.
Zurück zum Zitat Yang W, Lu J, Weng J, Jia W, Ji L et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L et al (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed
8.
Zurück zum Zitat Zhang L, Long J, Jiang W, Shi Y, He X et al (2016) Trends in chronic kidney disease in China. N Engl J Med 375:905–906CrossRefPubMed Zhang L, Long J, Jiang W, Shi Y, He X et al (2016) Trends in chronic kidney disease in China. N Engl J Med 375:905–906CrossRefPubMed
9.
Zurück zum Zitat Chue CD, Townend JN, Steeds RP, Ferro CJ (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96:817–823CrossRefPubMed Chue CD, Townend JN, Steeds RP, Ferro CJ (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96:817–823CrossRefPubMed
10.
Zurück zum Zitat Goh KL, Chan WK, Shiota S, Yamaoka Y (2011) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 16(Suppl 1):1–9CrossRefPubMedPubMedCentral Goh KL, Chan WK, Shiota S, Yamaoka Y (2011) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 16(Suppl 1):1–9CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M et al (2009) Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14:144–150CrossRefPubMed Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M et al (2009) Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14:144–150CrossRefPubMed
12.
Zurück zum Zitat Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D (2007) Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 121:229–238CrossRefPubMed Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D (2007) Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 121:229–238CrossRefPubMed
13.
Zurück zum Zitat Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M et al (2008) Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 103:3005–3010CrossRefPubMed Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M et al (2008) Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 103:3005–3010CrossRefPubMed
14.
Zurück zum Zitat Eshraghian A, Hashemi SA, Hamidian Jahromi A, Eshraghian H, Masoompour SM et al (2009) Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 54:1966–1970CrossRefPubMed Eshraghian A, Hashemi SA, Hamidian Jahromi A, Eshraghian H, Masoompour SM et al (2009) Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 54:1966–1970CrossRefPubMed
15.
Zurück zum Zitat Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas FF et al (2006) Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 12:6865–6868CrossRefPubMedPubMedCentral Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas FF et al (2006) Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 12:6865–6868CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kong X, Ma Y, Chen J, Luo Q, Yu X et al (2013) Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 28:641–651CrossRefPubMed Kong X, Ma Y, Chen J, Luo Q, Yu X et al (2013) Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 28:641–651CrossRefPubMed
18.
Zurück zum Zitat Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J et al (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089–2100CrossRefPubMed Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J et al (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089–2100CrossRefPubMed
19.
Zurück zum Zitat Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ et al (2006) Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med 260:255–262CrossRefPubMed Huang JF, Chuang WL, Dai CY, Ho CK, Hwang SJ et al (2006) Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med 260:255–262CrossRefPubMed
20.
Zurück zum Zitat Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G et al (2010) Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 21:217–221CrossRefPubMed Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G et al (2010) Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 21:217–221CrossRefPubMed
21.
Zurück zum Zitat Pan XR, Yang WY, Li GW, Liu J, National Diabetes Prevention and Control Cooperative Group (1997) Prevalence of diabetes and its risk factors in China 1994. Diabetes Care 20:1664–1669CrossRefPubMed Pan XR, Yang WY, Li GW, Liu J, National Diabetes Prevention and Control Cooperative Group (1997) Prevalence of diabetes and its risk factors in China 1994. Diabetes Care 20:1664–1669CrossRefPubMed
22.
Zurück zum Zitat Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P et al (2002) Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 13:376CrossRefPubMed Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P et al (2002) Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 13:376CrossRefPubMed
23.
Zurück zum Zitat Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM et al (2007) Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 18:225–229PubMed Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM et al (2007) Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 18:225–229PubMed
24.
Zurück zum Zitat Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP et al (2001) Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161:1989–1996CrossRefPubMed Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP et al (2001) Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161:1989–1996CrossRefPubMed
25.
Zurück zum Zitat Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y (2009) Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 75:96–103CrossRefPubMed Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y (2009) Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 75:96–103CrossRefPubMed
26.
Zurück zum Zitat Pietroiusti A, Giuliano M, Magrini A, Bergamaschi A, Galante A (2006) Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes. Diabetes Care 29:1399–1401CrossRefPubMed Pietroiusti A, Giuliano M, Magrini A, Bergamaschi A, Galante A (2006) Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes. Diabetes Care 29:1399–1401CrossRefPubMed
27.
Zurück zum Zitat Yanik S, Dogan Z, Sarikaya M, Ergul B, Filik L (2014) Helicobacter pylori eradication reduces microalbuminuria in type-2 diabetic patients: a prospective study. Acta Gastroenterol Belg 77:235–239PubMed Yanik S, Dogan Z, Sarikaya M, Ergul B, Filik L (2014) Helicobacter pylori eradication reduces microalbuminuria in type-2 diabetic patients: a prospective study. Acta Gastroenterol Belg 77:235–239PubMed
28.
Zurück zum Zitat Aydogan T, Ulas T, Selcoki Y, Alkan R, Yilmaz OC et al (2012) Effects of Helicobacter pylori eradication on proteinuria: a prospective study. Wien Klin Wochenschr 124:241–244CrossRefPubMed Aydogan T, Ulas T, Selcoki Y, Alkan R, Yilmaz OC et al (2012) Effects of Helicobacter pylori eradication on proteinuria: a prospective study. Wien Klin Wochenschr 124:241–244CrossRefPubMed
29.
Zurück zum Zitat Lin SY, Lin CL, Liu JH, Yang YF, Huang CC et al (2015) Association between Helicobacter pylori infection and the subsequent risk of end-stage renal disease: a nationwide population-based cohort study. Int J Clin Pract 69:604–610CrossRefPubMed Lin SY, Lin CL, Liu JH, Yang YF, Huang CC et al (2015) Association between Helicobacter pylori infection and the subsequent risk of end-stage renal disease: a nationwide population-based cohort study. Int J Clin Pract 69:604–610CrossRefPubMed
30.
Zurück zum Zitat Christodoulou DK, Milionis HJ, Pappa P, Katsanos KH, Sigounas D et al (2011) Association of Helicobacter pylori infection with cardiovascular disease–is it just a myth? Eur J Intern Med 22:191–194CrossRefPubMed Christodoulou DK, Milionis HJ, Pappa P, Katsanos KH, Sigounas D et al (2011) Association of Helicobacter pylori infection with cardiovascular disease–is it just a myth? Eur J Intern Med 22:191–194CrossRefPubMed
31.
Zurück zum Zitat Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M et al (2000) Diabetes mellitus and Helicobacter pylori infection. Nutrition 16:407–410CrossRefPubMed Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M et al (2000) Diabetes mellitus and Helicobacter pylori infection. Nutrition 16:407–410CrossRefPubMed
32.
Zurück zum Zitat Gillum RF (2004) Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the third national health and nutrition examination survey. J Natl Med Assoc 96:1470–1476PubMedPubMedCentral Gillum RF (2004) Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the third national health and nutrition examination survey. J Natl Med Assoc 96:1470–1476PubMedPubMedCentral
33.
Zurück zum Zitat Schottker B, Adamu MA, Weck MN, Muller H, Brenner H (2012) Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 220:569–574CrossRefPubMed Schottker B, Adamu MA, Weck MN, Muller H, Brenner H (2012) Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 220:569–574CrossRefPubMed
34.
Zurück zum Zitat Wang SZ, Shi YN, Zhao J, Wang ZD (2009) Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 89:958–961PubMed Wang SZ, Shi YN, Zhao J, Wang ZD (2009) Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 89:958–961PubMed
35.
Zurück zum Zitat Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A (2011) Extragastric manifestations of Helicobacter pylori infection. Helicobacter 16(Suppl 1):65–69CrossRefPubMed Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A (2011) Extragastric manifestations of Helicobacter pylori infection. Helicobacter 16(Suppl 1):65–69CrossRefPubMed
36.
Zurück zum Zitat Woodward M, Morrison C, McColl K (2000) An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 53:175–181CrossRefPubMed Woodward M, Morrison C, McColl K (2000) An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 53:175–181CrossRefPubMed
37.
Zurück zum Zitat Murray LJ, McCrum EE, Evans AE, Bamford KB (1997) Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 26:880–887CrossRefPubMed Murray LJ, McCrum EE, Evans AE, Bamford KB (1997) Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 26:880–887CrossRefPubMed
Metadaten
Titel
Association of H. pylori infection with chronic kidney disease among Chinese adults
verfasst von
Xianglei Kong
Dayu Xu
Feng Li
Xiaojing Ma
Hong Su
Dongmei Xu
Publikationsdatum
02.01.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1498-2

Weitere Artikel der Ausgabe 5/2017

International Urology and Nephrology 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.